Industry insights · UK & South Korea

Aesthetics, Unfiltered.

News and trends shaping aesthetic medicine across the United Kingdom and South Korea — from skin boosters and regenerative injectables to regulation and the next wave of K-beauty innovation.

Shop the range

United KingdomRegulation

Managing the Regulatory Risks of Exosome Treatments in UK Aesthetics

As regenerative therapies like exosomes gain popularity in the UK, practitioners must navigate complex indemnity and regulatory risks to ensure patient safety.

11 Sep 20264 min read

Global

Industry

The UK–Korea Aesthetic Corridor: Korean Fillers Arrive on British Shelves

As Korean-manufactured dermal fillers and skin boosters clear UK distribution, the cross-border pipeline between Seoul and British clinics is reshaping wholesale supply.

8 Sep 20265 min read

South Korea

Regenerative

Exosomes and Polynucleotides: Seoul's Regenerative Frontier

Regenerative injectables — exosomes, polynucleotides and salmon DNA protocols — are dominating Seoul treatment menus. We break down what's arriving and what UK practitioners should watch.

5 Sep 20266 min read

United Kingdom

Regenerative

Profhilo Structura: Bio-Remodelling Reaches New Depths

IBSA's Profhilo Structura extends bio-remodelling beyond the superficial fat compartments, giving UK practitioners a new tool for deeper structural rejuvenation.

2 Sep 20264 min read

United Kingdom

Skin Boosters

Why UK Clinics Are Moving Beyond Traditional Fillers

Skin boosters are the fastest-growing injectable category in UK aesthetic clinics in 2026 — bio-remodelling and hydrating protocols are overtaking volume-only filler as practitioners prioritise skin quality.

28 Aug 20265 min read

South Korea

Industry

How South Korea Became the Aesthetics Innovation Capital

From skin boosters to thread lifts, South Korea's aesthetic industry sets the global pace. Here's why K-beauty injectables are now exported to clinics worldwide — including the UK.

20 Aug 20265 min read

United Kingdom

Regulation

The 2026 Regulatory Landscape for UK Aesthetic Practitioners

From MHRA oversight of injectable devices to CPD requirements and insurance, here's what UK practitioners need to know about the regulatory shifts shaping aesthetic practice in 2026.

15 Aug 20266 min read